Human medicines European public assessment report (EPAR): Adrovance, alendronic acid,colecalciferol, Date of authorisation: 04/01/2007, Revision: 29, Status: Authorised

Submitted by Anonymous (not verified) on 12 February 2026 - 14:30

Human medicines European public assessment report (EPAR): Adrovance, alendronic acid,colecalciferol, Date of authorisation: 04/01/2007, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Foscan, temoporfin, Date of authorisation: 24/10/2001, Revision: 18, Status: Authorised

Submitted by Anonymous (not verified) on 12 February 2026 - 12:30

Human medicines European public assessment report (EPAR): Foscan, temoporfin, Date of authorisation: 24/10/2001, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Fosavance, alendronic acid,colecalciferol, Date of authorisation: 24/08/2005, Revision: 31, Status: Authorised

Submitted by Anonymous (not verified) on 12 February 2026 - 12:22

Human medicines European public assessment report (EPAR): Fosavance, alendronic acid,colecalciferol, Date of authorisation: 24/08/2005, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Kyinsu, insulin icodec,semaglutide, Date of authorisation: 24/11/2025, Status: Authorised

Submitted by Anonymous (not verified) on 12 February 2026 - 12:16

Human medicines European public assessment report (EPAR): Kyinsu, insulin icodec,semaglutide, Date of authorisation: 24/11/2025, Status: Authorised

SPOR and XEVMPD status update webinar - Q1 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 28 January 2026, 10:00 (CET) to 28 January 2026, 12:30 (CET)

Submitted by Anonymous (not verified) on 12 February 2026 - 9:42

SPOR and XEVMPD status update webinar - Q1 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 28 January 2026, 10:00 (CET) to 28 January 2026, 12:30 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More